William Blair on ARS Pharmaceuticals Inc (SPRY): FDA label update 'viewed positively' Mar 27, 2026 09:49AM
William Blair Reiterates Outperform Rating on ARS Pharmaceuticals Inc (SPRY) following Q4 results Mar 9, 2026 08:01AM
William Blair Reiterates Outperform Rating on ARS Pharmaceuticals Inc (SPRY) Nov 10, 2025 07:29AM
ARS Pharmaceuticals to Participate in Upcoming Investor Conferences May 27, 2025 08:00AM
William Blair Upgrades ARS Pharmaceuticals Inc (SPRY) to Outperform, 'Sets Up Second Half 2024 Approval and Launch' Feb 20, 2024 11:53AM


Jan 3, 2023 07:25AM William Blair Starts ARS Pharmaceuticals Inc (SPRY) at Outperform